Feature | April 03, 2017| Dave Fornell

Most Popular DAIC Content in March 2017

tryton side branch stent, dedicated coronary side branch stent

The FDA approval of the Tryton Side Branch Stent was the biggest technology news from March. It is deployed in the side branch artery using a standard single wire balloon-expandable stent delivery system. A conventional drug eluting stent is then placed in the main vessel.

April 3, 2017 — Here is the list of the top 25 most popular pieces of content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of March based on website analytics:  

1. FDA Clears First Dedicated Coronary Bifurcation Stent

2. ACC 2017 Late-Breaking Trials

3. FDA Clears Nano-coated Coronary Stent to Reduce DAPT

4. New Heart Attack Evaluation Cuts Unnecessary Tests, Time in ER

5. FDA Expands Indication for Melody Transcatheter Valve for Failed Surgical Valves

6. PCI, Drugs Equally Beneficial for Treating Fully Blocked Arteries - ACC.17

7. FDA Panel Supports Approval for First TAVR Embolic Protection Device

8. FDA Clears CoreValve Evolut Pro Transcatheter Aortic Valve

9. Collaboration by Metro Detroit Cardiologists Increases Cardiogenic Shock Survival Rate

10. VIDEO: Demonstration of the Tryton Dedicated Bifurcation Stent

11. U.K. Patent Court Rules in Edwards Lifesciences TAVR Case Against Boston Scientific

12. Benefits Shown for Treating All Clogged Arteries After a Heart Attack - ACC.17

13. Evolocumab Significantly Reduces Risk of Cardiovascular Events, LDL - ACC.17

14. TAVR Can Cause Silent Cerebral Microbleeds, Neurological Impairment - ACC.17

15. Teleflex Announces 510(k) Clearance and U.S. Launch of TrapLiner Catheter

16. Philips Launches Azurion Platform Angiography System

17. Henry Ford Hospital Study Shows 3-D Imaging Improves Fixing Broken Hearts

18. Medtronic Receives FDA Clearance for Reveal LINQ Insertable Cardiac Monitor With TruRhythm Detection

19. FDA Clears Artis Pheno Angiography System from Siemens Healthineers

20. Bioresorbable Stent Comparable to Xience at Two Year, But With Adverse Trends - ACC.17

21. Videos of Interventional Cardiac Technology Advances

22. Easier to Use iFR Equal to Outcomes of FFR in Coronary Lesion Evaluation - ACC.17

23. CT Scans Reveal Reduced Leaflet Motion After Aortic Valve Replacement - ACC.17

24. Biosensors Announces Enrollment of First Patient in New U.S. Pivotal BioFreedom Trial

25. TAVR Stands Equal to Surgical Valve Replacement - ACC.17

 

 

Most Popular DAIC Content in February 2017

Most Popular Cardiology Articles of 2016 From DAIC

Related Content

The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.20 annual meeting March 28-30, 2020, in Chicago. This includes five late-breaking clinical trial (LBCT) sessions and three featured clinical research sessions. There also are two LBCT deep-dive sessions where the experts will break down the hottest trials and attendees can find out what the impact might be on the practice of cardiology and patients.
Feature | ACC | April 09, 2020 | Dave Fornell, Editor
Here is the list of American College of Cardiology (ACC) practice-
ACC Cancels 2020 Conference Amid Coronavirus Concerns. #COVID19 #coronavirus #2019nCoV
Feature | ACC | March 09, 2020 | Dave Fornell, Editor
March 9, 2020 — Less than week after the American College of Cardiolog...
American College of Cardiology Names Douglas Drachman Next Annual Scientific Session Vice Chair

Image courtesy of Massachusetts General Hospital

News | ACC | October 08, 2019
Douglas Drachman, M.D., FACC, has been selected as the next vice chair of the American College of Cardiology’s (ACC)...
SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions. FFR in the cath lab.

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions.

Feature | ACC | March 27, 2019 | Greg Freiherr, Contributing Editor
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the a

The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.

Feature | ACC | March 19, 2019
The American College of Cardiology (ACC) released a list of the late
A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a